Sign up to our newsletter Subscribe
Challenges and Solutions for Budget Impact Analysis of Gene Therapies
< 1 min read|01/05/2020
International Cost-Effectiveness Thresholds and Modifiers for HTA Decision Making
OHE presents an overview on the use of cost-effectiveness thresholds (CETs) in a number of selected countries in their decision-making process for health technology assessments (HTAs). In addition to the different levels of CETs in these countries, this review examines whether an explicit…
OHE presents an overview on the use of cost-effectiveness thresholds (CETs) in a number of selected countries in their decision-making process for health technology assessments (HTAs). In addition to the different levels of CETs in these countries, this review examines whether an explicit or implicit CET is used, and the additional considerations (here termed ‘modifiers’) that are incorporated when funding and reimbursement decisions are made.
International Cost-Effectiveness Thresholds and Modifiers for HTA Decision Making
Zhang, K., Garau, M. (2020) International Cost-Effectiveness Thresholds and Modifiers for HTA Decision Making.
OHE Contract Research. Available from https://www.ohe.org/publications/international-cost-effectiveness-thresholds-and-modifiers-hta-decision-making/
